Zwitterionic Copolymer Coatings for Nonfouling Blood-Contacting Surfaces

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing blood-contacting medical devices face significant challenges with biofouling due to non-specific protein adsorption, leading to thrombosis, platelet activation, and inflammatory reactions, with conventional materials like poly(HEMA) and PEG showing limitations in water content and biocompatibility.

Innovation Solution

The use of zwitterionic copolymers with pendant zwitterionic, photoreactive, and hydrophobic groups for surface modification, which are applied via coating and crosslinked using light irradiation to inhibit protein adsorption and prevent plasticizer leaching.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional biomaterials like poly(HEMA) are used for surface modification, then the material can be applied to blood-contacting devices, but it has low water content and poor resistance to protein adsorption

Engineering Contradiction:
Improveresistance to protein adsorptionVSAvoidwater content
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The patent changes the chemical composition parameters of the polymer by incorporating zwitterionic groups (carboxybetaine, sulfobetaine, or phosphorylcholine) which have unique properties of being both hydrophilic and charge-neutral. This parameter change in molecular structure enables the polymer to achieve high water content (super-hydrophilicity) while simultaneously providing excellent resistance to protein adsorption, resolving the contradiction between these two properties that plagues conventional materials like poly(HEMA).

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention creates a composite polymer structure by combining zwitterionic monomers with hydrophobic or photoreactive monomers to form copolymers. This composite approach allows the zwitterionic segments to provide hydration and protein resistance while the hydrophobic segments can enhance mechanical properties and the photoreactive segments enable covalent bonding to surfaces, achieving multiple functions simultaneously including high water content and protein adsorption resistance.

Inventive Principle:
Principle #40Composite materials

2Reliability

If PEG is used for surface modification, then it provides hydrophilic properties, but it can induce adverse reactions including anti-PEG antibodies and tissue histologic changes

Engineering Contradiction:
ImprovebiocompatibilityVSAvoidadverse immune reactions
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent extracts and eliminates the problematic PEG component from the system by replacing it entirely with zwitterionic polymers. The zwitterionic groups (carboxybetaine, sulfobetaine, phosphorylcholine) provide similar or superior hydrophilic properties and protein resistance without the immunogenicity of PEG, thus taking out the harmful factor while preserving the beneficial hydrophilic characteristics needed for blood-contacting applications.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The zwitterionic copolymers are designed as disposable surface coatings that can be applied to medical devices. These coatings provide the necessary biocompatibility and protein resistance for their intended use lifecycle without requiring long-term stability in the body, allowing for simpler, more reliable materials that eliminate PEG-related immune issues while maintaining performance during the device's service life.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Reliability

If zwitterionic copolymers are applied for surface coating, then they provide nonfouling properties, but additional steps for crosslinking and functionalization are required

Engineering Contradiction:
Improvenonfouling capabilityVSAvoidnumber of processing steps
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent merges multiple functions into a single copolymer structure by incorporating zwitterionic groups (for nonfouling properties), hydrophobic groups (for surface adsorption), and photoreactive groups (for crosslinking) all within the same polymer chain. This merging allows the material to self-assemble on surfaces through hydrophobic interactions, form covalent bonds via photoreactive groups upon light exposure, and provide protein resistance simultaneously, reducing the need for separate processing steps while achieving comprehensive surface modification functionality.

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The zwitterionic copolymers effectively reduce biofouling, inhibit protein adsorption, and prevent plasticizer leaching, enhancing the biocompatibility and functionality of blood-contacting medical devices.

Implementation Method 1

irradiating the coated surface with light effective to crosslink the copolymer on the surface

Methodology Applied
Scientific EffectPhotopolymerization: Photopolymerisation

Implementation Method 2

an indestructible hydration layer formed on the polymer chain surface can repel the adsorption of biomolecules with high efficacy

Methodology Applied
Scientific EffectHydration: Hydrates

Implementation Method 3

hydration induced nonfouling capability is a predominant feature for a hydrophilic nonfouling polymer biomaterial

Methodology Applied
Scientific EffectHydration-induced nonfouling:

Implementation Method 4

the copolymer further comprises third repeating units, wherein each of the third repeating units comprises a hydrophobic group effective for adsorbing the copolymer to the surface

Methodology Applied
Scientific EffectHydrophobic interaction: Hydrophobe

Data Source

PatentUS12528967B2Zwitterionic copolymer coatings and related methods
Publication Date: 2026.01.20 UNIV OF WASHINGTON
  • US12528967B2 patent drawing
  • US12528967B2 patent drawing
  • US12528967B2 patent drawing

AI summary

Zwitterionic carboxybetaine copolymers and their use in coatings to impart non-fouling and functionality to surfaces, particularly surfaces of blood-contacting medical devices.